HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 35.87
+2.42 (7.23%)
At close: Jul 10, 2026
HitGen Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 579.23 | 525.43 | 426.76 | 371.07 | 329.65 | 311.06 |
Other Revenue | 0.14 | 0.14 | 0.23 | 0.26 | - | - |
| 579.37 | 525.57 | 426.99 | 371.32 | 329.65 | 311.06 | |
Revenue Growth (YoY) | 35.89% | 23.09% | 14.99% | 12.64% | 5.98% | 27.69% |
Cost of Revenue | 259.31 | 240.6 | 205.55 | 188.45 | 172.49 | 164.78 |
Gross Profit | 320.06 | 284.98 | 221.44 | 182.87 | 157.16 | 146.27 |
Selling, General & Admin | 106.8 | 102.56 | 90.02 | 90.86 | 89.79 | 77.18 |
Research & Development | 79.39 | 71.53 | 66.8 | 79.38 | 87.17 | 73.51 |
Other Operating Expenses | -13.44 | -15.09 | -17.13 | -0.36 | -0.86 | -1.31 |
Operating Expenses | 173.17 | 159.42 | 141.21 | 172.65 | 178.37 | 149.39 |
Operating Income | 146.89 | 125.56 | 80.23 | 10.22 | -21.21 | -3.11 |
Interest Expense | -11.28 | -11.3 | -13.04 | -13.04 | -9.83 | -6.56 |
Interest & Investment Income | 23.02 | 23.59 | 29.11 | 26.92 | 20.13 | 23.53 |
Currency Exchange Gain (Loss) | -3.32 | -3.32 | -0.11 | -0.07 | 19.61 | -5.15 |
Other Non Operating Income (Expenses) | -9.88 | -0.47 | -0.15 | -0.19 | -0.09 | -0.15 |
EBT Excluding Unusual Items | 145.44 | 134.06 | 96.05 | 23.84 | 8.6 | 8.56 |
Impairment of Goodwill | - | - | - | -13.03 | -11.76 | - |
Gain (Loss) on Sale of Investments | -17.93 | -20.47 | -38.68 | -1.28 | 1.35 | -1.15 |
Gain (Loss) on Sale of Assets | - | - | 0.79 | 0.95 | - | -0.01 |
Other Unusual Items | 7.3 | 7.3 | 4.6 | 24.97 | 14.25 | 48.44 |
Pretax Income | 134.82 | 120.89 | 62.76 | 35.44 | 12.44 | 55.83 |
Income Tax Expense | 11.02 | 10.83 | 12.84 | -5.42 | -13.05 | -7.55 |
Earnings From Continuing Operations | 123.8 | 110.05 | 49.92 | 40.86 | 25.5 | 63.38 |
Minority Interest in Earnings | -1.08 | -0.55 | 1.43 | -0.14 | -0.23 | - |
Net Income | 122.72 | 109.51 | 51.36 | 40.72 | 25.27 | 63.38 |
Net Income to Common | 122.72 | 109.51 | 51.36 | 40.72 | 25.27 | 63.38 |
Net Income Growth | 86.79% | 113.22% | 26.13% | 61.16% | -60.14% | -1.00% |
Shares Outstanding (Basic) | 408 | 406 | 395 | 407 | 421 | 396 |
Shares Outstanding (Diluted) | 408 | 406 | 395 | 407 | 421 | 396 |
Shares Change (YoY) | 7.48% | 2.66% | -2.98% | -3.31% | 6.30% | 5.19% |
EPS (Basic) | 0.30 | 0.27 | 0.13 | 0.10 | 0.06 | 0.16 |
EPS (Diluted) | 0.30 | 0.27 | 0.13 | 0.10 | 0.06 | 0.16 |
EPS Growth | 73.79% | 107.69% | 30.00% | 66.67% | -62.50% | -5.88% |
Free Cash Flow | 53.91 | 55.82 | 56.34 | 71.47 | -34.61 | -96.37 |
Free Cash Flow Per Share | 0.13 | 0.14 | 0.14 | 0.18 | -0.08 | -0.24 |
Dividend Per Share | 0.130 | 0.130 | 0.060 | 0.050 | - | 0.050 |
Dividend Growth | 116.67% | 116.67% | 20.00% | - | - | - |
Gross Margin | 55.24% | 54.22% | 51.86% | 49.25% | 47.67% | 47.02% |
Operating Margin | 25.35% | 23.89% | 18.79% | 2.75% | -6.44% | -1.00% |
Profit Margin | 21.18% | 20.84% | 12.03% | 10.97% | 7.66% | 20.38% |
Free Cash Flow Margin | 9.30% | 10.62% | 13.20% | 19.25% | -10.50% | -30.98% |
EBITDA | 184.38 | 163.07 | 117.8 | 47.52 | 16.82 | 36.71 |
EBITDA Margin | 31.82% | 31.03% | 27.59% | 12.80% | 5.10% | 11.80% |
D&A For EBITDA | 37.49 | 37.51 | 37.57 | 37.3 | 38.03 | 39.82 |
EBIT | 146.89 | 125.56 | 80.23 | 10.22 | -21.21 | -3.11 |
EBIT Margin | 25.35% | 23.89% | 18.79% | 2.75% | -6.44% | -1.00% |
Effective Tax Rate | 8.17% | 8.96% | 20.45% | - | - | - |
Revenue as Reported | 579.37 | 525.57 | 426.99 | 371.32 | 329.65 | 311.06 |
Advertising Expenses | - | 1.01 | 0.54 | 0.43 | 0.6 | 0.3 |